This article is part of the Technology Insight series, made possible with funding from Intel. In case you hadn’t noticed, solid-state drives keep getting bigger and faster. Back in 2008, a ...
1% of oral dose for 30-fold lung exposure and reduced cardiotoxicityA cost-effective, easily accessible, user-friendly potential treatment/prevention option TLC19 utilizes TLC’s existing proprietary ...
TAIPEI, Taiwan, April 03, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (“TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and ...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to ...
(RTTNews) - Taiwanese specialty pharmaceutical company Taiwan Liposome Co. Ltd. (TLC) announced Friday the submission of an Investigational New Drug (IND) Application to the Taiwan Food and Drug ...